AXREM launches clinical advisory group to strengthen innovation

AXREM has formed a clinical advisory group (CAG) aiming to further embed clinical insight and patient-focused thinking into the trade association’s work. The CAG has been established to support the AXREM executive and its special focus groups (SFG) with expert clinical advice, input and validation across
initiatives including publications, policy development and external communications.

PACSHealth UK/EMEA managing director Kaye Bonython has been appointed convenor of the group. She commented: “I am currently marking the 50th anniversary of my first steps in the imaging world. It’s safe to say things have changed a lot, but my commitment to ‘patient first’ has never wavered.
“I have always been excited by the new and emerging technologies in modality and image management (including beyond radiology) and how it can improve the patient experience and clinical outcomes, so involvement with AXREM enables me to assess and validate at both theoretical and practical levels.

“The AXREM CAG will ensure the executive and SFGs can call upon CAG to assist and advise on clinical detail required for any publications, strategies and policies. The team will be available for both consultation and advice that ensures external communications are consistent, accurate and clinically validated at the highest level. They can also be directed to assist external organisations and bodies as requested by the AXREM CEO.”

Picture: AXREM CEO Sally Edgington and CAG convenor Kaye Bonython.

Read this report on page 15 of the September 2025 issue of RAD Magazine.